Clinical Trial Update: Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 trial assessing CsA ophthalmic gel for safety and efficacy in moderate to severe dry eye disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• CsA ophthalmic gel (cyclosporine ophthalmic gel)

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED